Martens, Thomas W., MD
Medical Director, International Diabetes Center
About

Park Nicollet Medical Group title: Consultant in internal medicine, Park Nicollet Clinic

Other offices: Internal Medicine, Park Nicollet Brookdale Clinic, Brooklyn Center, Minnesota

Joined the Institute: 2015

Education and training: Residency in Internal Medicine, Hennepin County Medical Center; University of Wisconsin Medical School.

Overview/research interests: Clinical aspects of type 2 diabetes mellitus (T2DM) management, quality improvement in the management of T2DM, bariatric surgery and T2DM. Translation and implementation of diabetes technology into clinical practice. Ambulatory Glucose Profile in T2DM.

Current research activities and funding:

  • Principle Investigator: “Beyond A1C: Individualizing Diabetes Management Using Professional Continuous Glucose Monitoring in Primary Care” Abbott Labs-funded quality improvement project implementing professional CGM in a primary care setting
  • Sub-Principle Investigator: NIH-funded GRADE Study
  • Sub-Principle Investigator: University of Cambridge-sponsored ApCam-11: Day and night automated closed loop glucose control system using Florance-M predictive algorithms
Affiliation
positions
  • Sr. Research Investigator, Diabetes
  • Medical Director, International Diabetes Center, International Diabetes Center 2015 -
  • Publications
    selected publications
    Journal Article
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the OmnipodĀ® 5 System
    Diabetes Research and Clinical Practice. 2022
  • How use of continuous glucose monitoring can address therapeutic inertia in primary care
    Postgraduate Medicine. 2022
  • Primary care and diabetes technologies and treatments
    Diabetes Technology & Therapeutics. 2022
  • Continuous glucose monitoring and glycemic control in patients with type 2 diabetes treated with basal insulin-reply
    JAMA. 2021
  • Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial
    JAMA. 2021
  • Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care
    Journal of Diabetes Science and Technology. 2021
  • Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
    Diabetes, Obesity & Metabolism. 2021
  • Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)
    Postgraduate Medicine. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes
    Diabetes care. 2021
  • Primary care and diabetes technologies and treatments
    Diabetes Technology & Therapeutics. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin
    Diabetes care. 2021
  • Trial of a new diabetes education model: closing the gap in health disparity for people with diabetes
    Journal of Diabetes Science and Technology. 2021
  • International Diabetes Center: COVID-19 won't stop us from fulfilling our mission
    Journal of Diabetes Science and Technology. 2020
  • Quick Info
     
    Collaboration
    More Info